Abstract

NK cells are a part of the innate antiviral response. Their activity is regulated by signals from the surface receptors. Some of them, known as killer cell immunoglobulin-like receptors (KIRs), determine the quality and intensity of the immunological response, together with their ligands (HLA class I). KIR genes are very polymorphic, and this is reflected in the NK activity modulation. The stimulation of NK cells, especially in the early stages of the infection, can reduce the transmission of HIV or slow down the progression of infection. The varied KIR/HLA repertoire is a limiting factor for the risk of HIV infection and disease progression. Such diversity enables optimal regulation of NK cells and maintenance of the balance between activation to eliminate infected cells and inhibition. The control of NK cell activity via KIR3DL1/3DS1 and HLA-Bw4 (especially Bw4-80I) seems to be very important in the HIV context. With a few exceptions, it leads to a reduction of susceptibility to HIV infection and better viremia control, and slows down depletion of CD4+ T cells. Incompatibility of sexual partners for KIRs and HLA may oblige NK cells from the exposed partner to reject incoming cells from the HIV-positive partner. The presence of the inhibitory KIR, in the absence of its ligand, results in a lower threshold of NK cell activation, which reduces the chance of infection. The presence of an inhibitory receptor with a low affinity to the ligand (KIR2DL3+HLA-C1) is associated with lower susceptibility, and the effective NK cell inhibition (KIR2DL2+HLA-C1) results in increased susceptibility to HIV infection. The advantage of activating KIRs, especially in the presence of their ligands, is associated with higher cytolytic abilities, and thus reduced risk of HIV infection. If the virus is not eliminated in an early stage of infection, massive activation of NK is unfavorable due to the excessive stimulation of the immune system.

References

• 1. Aghafar M.Z., Witt C., Kamarulzaman A., Ismail R., Lederman M.M.,Rodriguez B., Senitzer D., Lee S., Price P.: Genetic variations in locirelevant to natural killer cell function are affected by ethnicity butare generally not correlated with susceptibility to HIV-1. Tissue Antigens,2012; 79: 367-371
  Google Scholar
• 2. Alter G., Altfeld M.: NK cells in HIV-1 infection: evidence for theirrole in the control of HIV-1 infection. J. Intern. Med., 2009; 265: 29-42
  Google Scholar
• 3. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., SchneidewindA., Streeck H., Waring M., Meier A., Brander C., Lifson J.D.,Allen T.M., Carrington M., Altfeld M.: Differential natural killer cellmediatedinhibition of HIV-1 replication based on distinct KIR/HLAsubtypes. J. Exp. Med., 2007; 204: 3027-3036
  Google Scholar
• 4. Alter G., Rihn S., Walter K., Nolting A., Martin M., Rosenberg E.S.,Miller J.S., Carrington M., Altfeld M.: HLA class I subtype-dependentexpansion of KIR3DS1+ and KIR3DL1+ NK cells during acute humanimmunodeficiency virus type 1 infection. J. Virol., 2009; 83: 6798-6805
  Google Scholar
• 5. Anel A., Aguiló J.I., Catalán E., Garaude J., Rathore M.G., Pardo J.,Villalba M.: Protein kinase C-θ (PKC-θ) in natural killer cell functionand anti-tumor immunity. Front. Immunol., 2012; 3: 187
  Google Scholar
• 6. Aranda-Romo S., Garcia-Sepulveda C.A., Comas-García A., LovatoSalasF., Salgado-Bustamante M., Gómez-Gómez A., Noyola D.E.: Killer-cellimmunoglobulin-like receptors (KIR) in severe A (H1N1) 2009influenza infections. Immunogenetics, 2012; 64: 653-662
  Google Scholar
• 7. Arenzana-Seisdedos F., Parmentier M.: Genetics of resistance toHIV infection: role of co-receptors and co-receptor ligands. Semin.Immunol., 2006; 18: 387-403
  Google Scholar
• 8. Arnett K.L., Huang W., Valiante N.M., Barber L.D., Parham P.: TheBw4/Bw6 difference between HLA-B
  Google Scholar
• 9. Ballan W.M., Vu B.A., Long B.R., Loo C.P., Michaëlsson J., BarbourJ.D., Lanier L.L., Wiznia A.A., Abadi J., Fennelly G.J., Rosenberg M.G.,Nixon D.F.: Natural killer cells in perinatally HIV-1-infected childrenexhibit less degranulation compared to HIV-1-exposed uninfectedchildren and their expression of KIR2DL3, NKG2C, and NKp46 correlateswith disease severity. J. Immunol., 2007; 179: 3362-3370
  Google Scholar
• 10. Barbour J.D., Sriram U., Caillier S.J., Levy J.A., Hecht F.M., OksenbergJ.R.: Synergy or independence? Deciphering the interaction ofHLA Class I and NK cell KIR alleles in early HIV-1 disease progression.PLoS Pathog., 2007; 3: e43
  Google Scholar
• 11. Bashirova A.A., Thomas R., Carrington M.: HLA/KIR restraint ofHIV: surviving the fittest. Annu. Rev. Immunol., 2011; 29: 295-317
  Google Scholar
• 12. Beltrame L.M., Sell A.M., Moliterno R.A., Clementino S.L., CardozoD.M., Dalalio M.M., Fonzar U.J., Visentainer J.E.: Influence of KIR genesand their HLA ligands in susceptibility to dengue in a population fromsouthern Brazil. Tissue Antigens, 2013; 82: 397-404
  Google Scholar
• 13. Biedroń M., Kuliczkowski K., Mazur G., Wróbel T.: Receptorykomórek NK. Adv. Clin. Exp. Med., 2003; 12: 529-535
  Google Scholar
• 14. Bielawska-Pohl A., Pajtasz-Piasecka E., Duś D.: Związki komórekNK z komórkami dendrytycznymi. Postępy Hig. Med. Dośw., 2013;67: 192-200
  Google Scholar
• 15. Bimber B., O’Connor D.H.: KIRigami: the case for studying NK cellreceptors in SIV+ macaques. Immunol. Res., 2008; 40: 235-243
  Google Scholar
• 16. Boudreau J.E., Mulrooney T.J., Le Luduec J.B., Barker E., Hsu K.C.:KIR3DL1 and HLA-B density and binding calibrate NK education andresponse to HIV. J. Immunol., 2016; 196: 3398-3410
  Google Scholar
• 17. Boulet S., Sharafi S., Simic N., Bruneau J., Routy J.P., Tsoukas C.M.,Bernard N.F.: Increased proportion of KIR3DS1 homozygotes in HIVexposeduninfected individuals. AIDS, 2008; 22: 595-599
  Google Scholar
• 18. Boulet S., Song R., Kamya P., Bruneau J., Shoukry N.H., TsoukasC.M., Bernard N.F.: HIV protective KIR3DL1 and HLA-B genotypes influenceNK cell function following stimulation with HLA-devoid cells.J. Immunol. 2010; 184: 2057-2064
  Google Scholar
• 19. Carr W.H., Rosen D.B., Arase H., Nixon D.F., Michaelsson J., LanierL.L.: Cutting edge: KIR3DS1, a gene implicated in resistance to progressionto AIDS, encodes a DAP12-associated receptor expressed on NKcells that triggers NK cell activation. J. Immunol., 2007; 178: 647-651
  Google Scholar
• 20. Carrington M., O’Brien S.J.: The influence of HLA genotype onAIDS. Annu. Rev. Med., 2003; 54: 535-551
  Google Scholar
• 21. Chavan V.R., Chaudhari D., Ahir S., Ansari Z., Mehta P., ManiaPramanikJ.: Variations in KIR genes: a study in HIV-1 serodiscordantcouples. BioMed Res. Int., 2014; 2014: 891402
  Google Scholar
• 22. Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C.,Kumarasamy N., Hakim J.G., Kumwenda J., Grinsztejn B., Pilotto J.H.,Godbole S.V., Mehendale S., Chariyalertsak S., Santos B.R., Mayer K.H.i wsp.: Prevention of HIV-1 infection with early antiretroviral therapy.N. Engl. J. Med., 2011; 365: 493-505
  Google Scholar
• 23. Di Bona D., Scafidi V., Plaia A., Colomba C., Nuzzo D., Occhino C.,Tuttolomondo A., Giammanco G., De Grazia S., Montalto G., Duro G.,Cippitelli M., Caruso C.: HLA and killer cell immunoglobulin-like receptorsinfluence the natural course of CMV infection. J. Infect. Dis.,2014; 210: 1083-1089
  Google Scholar
• 24. Estefanía E., Gómez-Lozano N., Portero F., de Pablo R., Solís R.,Sepúlveda S., Vaquero M., González M.A., Suárez E., Roustán G., VilchesC.: Influence of KIR gene diversity on the course of HSV-1 infection:resistance to the disease is associated with the absence of KIR2DL2and KIR2DS2. Tissue Antigens, 2007; 70: 34-41
  Google Scholar
• 25. Fadda L., Alter G.: KIR/HLA: genetic clues for a role of NK cells inthe control of HIV. Adv. Exp. Med. Biol., 2011; 780: 27-36
  Google Scholar
• 26. Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A.:Virus Taxonomy. Classification and Nomenclature of Viruses. EightReport of the International Committee on Taxonomy of Viruses. ElsevierInc., London, 2005
  Google Scholar
• 27. Flores-Villanueva P.O., Yunis E.J., Delgado J.C., Vittinghoff E., BuchbinderS., Leung J.Y., Uglialoro A.M., Clavijo O.P., Rosenberg E.S.,Kalams S.A., Braun J.D., Boswell S.L., Walker B.D., Goldfeld A.E.: Controlof HIV-1 viremia and protection from AIDS are associated withHLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA, 2001; 98: 5140-5145
  Google Scholar
• 28. Frazier W.R., Steiner N., Hou L., Dakshanamurthy S., Hurley C.K.:Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increasedbinding to its HLA-C ligand. J. Immunol., 2013; 190: 6198-6208
  Google Scholar
• 29. Gao X., Jiao Y., Wang L., Liu X., Sun W., Cui B., Chen Z., Zhao Y.:Inhibitory KIR and specific HLA-C gene combinations confer susceptibilityto or protection against chronic hepatitis B. Clin. Immunol.,2010; 137: 139-146
  Google Scholar
• 30. Gardiner C.M.: Killer cell immunoglobulin-like receptors on NKcells: the how, where and why. Int. J. Immunogenet., 2008; 35: 1-8
  Google Scholar
• 31. Gaudieri S., DeSantis D., McKinnon E., Moore C., Nolan D., WittC.S., Mallal S.A., Christiansen F.T.: Killer immunoglobulin-like receptorsand HLA act both independently and synergistically to modifyHIV disease progression. Genes Immun., 2005; 6: 683-690
  Google Scholar
• 32. Gaudieri S., Nolan D., McKinnon E., Witt C.S., Mallal S., ChristiansenF.T.: Associations between KIR epitope combinations expressedby HLA-B/-C haplotypes found in an HIV-1 infected study populationmay influence NK mediated immune responses. Mol. Immunol.2005; 42: 557-560
  Google Scholar
• 33. Gillespie G.M., Bashirova A., Dong T., McVicar D.W., Rowland-JonesS.L., Carrington M.: Lack of KIR3DS1 binding to MHC class I Bw4 tetramersin complex with CD8+ T cell epitopes. AIDS Res. Hum. Retroviruses,2007; 23: 451-455
  Google Scholar
• 34. Gonzaga R., Matzinger P., Perez-Diez A.: Resident peritoneal NKcells. J. Immunol., 2011; 187: 6235-6242
  Google Scholar
• 35. González-Galarza F.F., Christmas S., Middleton D., Jones A.R.: Allelefrequency net: a database and online repository for immune genefrequencies in worldwide populations. Nucleic Acids Res., 2011; 39:D913-D919
  Google Scholar
• 36. González-Galarza F.F., Takeshita L.Y., Santos E.J., Kempson F., MaiaM.H., da Silva A.L., Teles e Silva A.L., Ghattaoraya G.S., Alfirevic A., JonesA.R., Middleton D.: Allele frequency net 2015 update: new featuresfor HLA epitopes, KIR and disease and HLA adverse drug reactionassociations. Nucleic Acids Res., 2015; 43: D784-D788
  Google Scholar
• 37. Gooneratne S.L., Center R.J., Kent S.J., Parsons M.S.: Functionaladvantage of educated KIR2DL1+ natural killer cells for anti-HIV-1 antibody-dependentactivation. Clin. Exp. Immunol., 2016; 184: 101-109
  Google Scholar
• 38. Gooneratne S.L., Richard J., Lee W.S., Finzi A., Kent S.J., ParsonsM.S.: Slaying the Trojan Horse: natural killer cells exhibit robust anti–HIV-1 antibody-dependent activation and cytolysis against allogeneicT cells. J. Virol., 2015; 89: 97-109
  Google Scholar
• 39. Guerini F.R., Clerici M.: NK cells in human disease: an evolvingstory. Clin. Immunol., 2012; 143: 203-206
  Google Scholar
• 40. Guerini F.R., Lo Caputo S., Gori A., Bandera A., Mazzotta F., UgliettiA., Zanzottera M., Maserati R., Clerici M.: Under representation of theinhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIVexposed seronegative individuals. J. Infect. Dis., 2011; 203: 1235-1239
  Google Scholar
• 41. Habegger de Sorrentino A., Sinchi J.L., Marinic K., López R., IliovichE.: KIR-HLA-A and B alleles of the Bw4 epitope against HIV infectionin discordant heterosexual couples in Chaco Argentina. Immunology,2013; 140: 273-279
  Google Scholar
• 42. Hens J., Jennes W., Kestens L.: The role of NK cells in HIV-1 protection:autologous, allogeneic or both? AIDS Res. Ther., 2016; 13: 15
  Google Scholar
• 43. Hernández-Ramírez D., Esparza-Pérez M.A., Ramirez-GarcialunaJ.L., Arguello J.R., Mandeville P.B., Noyola D.E., García-Sepúlveda C.A.:Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts inHIV-infected Mexican mestizos. Immunogenetics, 2015; 67: 413-424
  Google Scholar
• 44. Hilton H.G., Guethlein L.A., Goyos A., Nemat-Gorgani N., BushnellD.A., Norman P.J., Parham P.: Polymorphic HLA-C receptors balancethe functional characteristics of KIR haplotypes. J. Immunol., 2015;195: 3160-3170
  Google Scholar
• 45. Iannello A., Debbeche O., Samarani S., Ahmad A.: Antiviral NK cellresponses in HIV infection: I. NK cell receptor genes as determinants ofHIV resistance and progression to AIDS. J. Leukoc. Biol., 2008; 84: 1-26
  Google Scholar
• 46. Ivanova D., Krempels R., Ryfe J., Weitzman K., Stephenson D., GigleyJ.P.: NK cells in mucosal defense against infection. Biomed Res.Int., 2014; 2014: 413982
  Google Scholar
• 47. Ivarsson M.A., Michaëlsson J., Fauriat C.: Activating killer cell Ig–like receptors in health and disease. Front. Immunol., 2014; 5: 184
  Google Scholar
• 48. Jamil K.M., Khakoo S.I.: KIR/HLA interactions and pathogen immunity.J. Biomed. Biotechnol., 2011; 2011: 298348
  Google Scholar
• 49. Jennes W., Verheyden S., Demanet C., Adjé-Touré C.A., VuylstekeB., Nkengasong J.N., Kestens L.: Cutting edge: resistance to HIV-1infection among African female sex workers is associated with inhibitoryKIR in the absence of their HLA ligands. J. Immunol., 2006;177: 6588-6592
  Google Scholar
• 50. Jennes W., Verheyden S., Demanet C., Menten J., Vuylsteke B.,Nkengasong J.N., Kestens L.: Low CD4+ T cell counts among AfricanHIV-1 infected subjects with group B KIR haplotypes in the absenceof specific inhibitory KIR ligands. PLoS One, 2011; 6: e17043
  Google Scholar
• 51. Jennes W., Verheyden S., Mertens J.W., Camara M., Seydi M., Diey T.N., Mboup S., Demanet C., Kestens L.: Inhibitory KIR/HLA incompatibilitybetween sexual partners confers protection against HIV-1transmission. Blood, 2013; 121: 1157-1164
  Google Scholar
• 52. Jiang W., Johnson C., Jayaraman J., Simecek N., Noble J., MoffattM.F., Cookson W.O., Trowsdale J., Traherne J.A.: Copy number variationleads to considerable diversity for B but not A haplotypes of thehuman KIR genes encoding NK cell receptors. Genome Res., 2012;22: 1845-1854
  Google Scholar
• 53. Jiang Y., Chen O., Cui C., Zhao B., Han X., Zhang Z., Liu J., Xu J., HuQ., Liao C., Shang H.: KIR3DS1/L1 and HLA-Bw4-80I are associated withHIV disease progression among HIV typical progressors and long-termnonprogressors. BMC Infect. Dis., 2013; 13: 405
  Google Scholar
• 54. Jost S., Altfeld M.: Evasion from NK cell-mediated immune responsesby HIV-1. Microbes Infect. Inst. Pasteur, 2012; 14: 904-915
  Google Scholar
• 55. Kalyanaraman N., Thayumanavan L., Jayalakshmi M.: KIR: HLAassociation with clinical manifestations of HBV infection in Madurai,south India. J. Genet., 2016; 95: 13-19
  Google Scholar
• 56. Kärre K.: Role of target histocompatibility antigens in regulationof natural killer activity: a reevaluation and a hypothesis. W: Mechanismsof Cytotoxicity by Natural Killer Cells. red.: Herberman R.B.,Callewaert D. Acad. Press, London, 1985, 81-92 57 Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., AstemborskiJ., Cheng J., Goedert J.J., Vlahov D., Hilgartner M., Cox S., LittleA.M., Alexander G.J., Cramp M.E., O’Brien S.J. i wsp.: HLA and NK cellinhibitory receptor genes in resolving hepatitis C virus infection.Science, 2004; 305: 872-874
  Google Scholar
• 57. supertypealleles influences the progression of HIV-1 infection in a Zambianpopulation. Hum. Immunol., 2005; 66: 285-289
  Google Scholar
• 58. Körner C., Granoff M.E., Amero M.A., Sirignano M.N., Vaidya S.A.,Jost S., Allen T.M., Rosenberg E.S., Altfeld M.: Increased frequencyand function of KIR2DL1-3+ NK cells in primary HIV-1 infection aredetermined by HLA-C group haplotypes. Eur. J. Immunol., 2014; 44:2938-2948
  Google Scholar
• 59. Kuśnierczyk P.: Sensing the self: structure, genetics, biologicalfunction and possible disease associations of KIR genes and molecules.W: Leading-Edge Immunology Research, red.:Veskler B.A., NovaScience Publishers, New York, 2006, 95-125
  Google Scholar
• 60. Kuśnierczyk P., Mozer-Lisewska I., Zwolińska K., Kowala-PiaskowskaA.E., Bura M., Bereszyńska I., Pauli A., Żeromski J.: Contributionof genes for killer cell immunoglobulin-like receptors (KIR) to thesusceptibility to chronic hepatitis C virus infection and to viremia.Hum. Immunol., 2015; 76: 102-108
  Google Scholar
• 61. Lee S.H., Biron C.A.: Here today – not gone tomorrow: roles foractivating receptors in sustaining NK cells during viral infections. Eur.J. Immunol., 2010; 40: 923-932
  Google Scholar
• 62. Locatelli F., Pende D., Mingari M.C., Bertaina A., Falco M., MorettaA., Moretta L.: Cellular and molecular basis of haploidenticalhematopoietic stem cell transplantation in the successful treatmentof high-risk leukemias: role of alloreactive NK cells. Front. Immunol.,2013; 4: 15
  Google Scholar
• 63. Long B.R., Ndhlovu L.C., Oksenberg J.R., Lanier L.L., Hecht F.M.,Nixon D.F., Barbour J.D.: Conferral of enhanced natural killer cell functionby KIR3DS1 in early human immunodeficiency virus type 1 infection.J. Virol., 2008; 82: 4785-4792
  Google Scholar
• 64. López-Vázquez A., Miña-Blanco A., Martínez-Borra J., Njobvu P.D.,Suárez-Alvarez B., Blanco-Gelaz M.A., González S., Rodrigo L., López–Larrea C.: Interaction between KIR3DL1 and HLA-B
  Google Scholar
• 65. Martin M.P., Carrington M.: Immunogenetics of HIV disease. Immunol.Rev., 2013; 254: 245-264
  Google Scholar
• 66. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J.,Buchbinder S., Hoots K., Vlahov D., Trowsdale J., Wilson M., O’BrienS.J., Carrington M.: Epistatic interaction between KIR3DS1 and HLA-Bdelays the progression to AIDS. Nat. Genet., 2002; 31: 429-434
  Google Scholar
• 67. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., ColomboS., Brown E.E., Shupert W.L., Phair J., Goedert J.J., Buchbinder S.,Kirk G.D., Telenti A., Connors M. i wsp.: Innate partnership of HLA-Band KIR3DL1 subtypes against HIV-1. Nat. Genet., 2007; 39: 733-740
  Google Scholar
• 68. Mazurek-Mochol M., Majorczyk E., Banach J., Dembowska E., PawlikA., Kuśnierczyk P.: Are KIR genes associated with clinical parametersin the course of periodontitis? Postępy Hig. Med. Dośw., 2014;68: 1145-1151
  Google Scholar
• 69. Merino A., Malhotra R., Morton M., Mulenga J., Allen S., HunterE., Tang J., Kaslow R.A.: Impact of a functional KIR2DS4 allele on heterosexualHIV-1 transmission among discordant Zambian couples.J. Infect. Dis., 2011; 203: 487-495
  Google Scholar
• 70. Moesta A.K., Parham P.: Diverse functionality among human NKcell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, andKIR2DL3. Front. Immunol., 2012; 3: 336
  Google Scholar
• 71. Montoya C.J., Velilla P.A., Chougnet C., Landay A.L., Rugeles M.T.:Increased IFN-g production by NK and CD3+/CD56+ cells in sexuallyHIV-1-exposed but uninfected individuals. Clin. Immunol., 2006;120: 138-146
  Google Scholar
• 72. Mori M., Wichukchinda N., Miyahara R., Rojanawiwat A., PathipvanichP., Tsuchiya N., Miura T., Yasunami M., Ariyoshi K., SawanpanyalertP.: The effect of KIR2D-HLA-C receptor-ligand interactionson clinical outcome in a HIV-1 CRF01_AE-infected Thai population.AIDS, 2015; 29: 1607-1615
  Google Scholar
• 73. Morice W.G.: The immunophenotypic attributes of NK cells andNK-cell lineage lymphoproliferative disorders. Am. J. Clin. Pathol.,2007; 127: 881-886
  Google Scholar
• 74. Mozer-Lisewska I., Zwolińska K., Kowala-Piaskowska A.E., BuraM., Rozpłochowski B., Pauli A., Żeromski J., Piasecki E., KuśnierczykP.: Genetic (KIR, HLA-C) and some clinical parameters influencingthe level of liver enzymes and early virologic response in patientswith chronic hepatitis C. Arch. Immunol. Ther. Exp., 2016; 64: 65-73
  Google Scholar
• 75. Nguyen P.V., Kafka J.K., Ferreira V.H., Roth K., Kaushic C.: Innateand adaptive immune responses in male and female reproductivetracts in homeostasis and following HIV infection. Cell. Mol. Immunol.,2014; 11: 410-427
  Google Scholar
• 76. Niepiekło-Miniewska W., Zuk N., Dubis J., Kurpisz M., Senitzer D.,Havrylyuk A., Grendziak R., Witkiewicz W., Chopyak V., Kuśnierczyk P.:Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of whichis also lacking KIR3DL2. Arch. Immunol. Ther. Exp., 2014; 62: 423-429
  Google Scholar
• 77. Nowak I., Barcz E., Majorczyk E., Malinowski A., Wilczyński J.R., BanasikM., Motak-Pochrzęst H., Kuśnierczyk P.: Genetic polymorphismof KIR2DL4 in the Polish population. Tissue Antigens, 2015; 85: 450-457
  Google Scholar
• 78. O’Connor G.M., Guinan K.J., Cunningham R.T., Middleton D., ParhamP., Gardiner C.M.: Functional polymorphism of the KIR3DL1/S1receptor on human NK cells. J. Immunol., 2007; 178: 235-241
  Google Scholar
• 79. O’Connor G.M., Vivian J.P., Gostick E., Pymm P., Lafont B.A., PriceD.A., Rossjohn J., Brooks A.G., McVicar D.W.: Peptide-dependentrecognition of HLA-B57:01 by KIR3DS1. J. Virol., 2015; 89: 5213-5221
  Google Scholar
• 80. Pan N., Qiu J., Sun H., Miao F., Shi Q., Xu J., Jiang W., Jin H., Xie W.,He Y., Zhang J.: Combination of human leukocyte antigen and killercell immunoglobulin-like receptor genetic background influences theonset age of hepatocellular carcinoma in male patients with hepatitisB virus infection. Clin. Dev. Immunol., 2013; 2013: 874514
  Google Scholar
• 81. Parham P., Abi-Rached L., Matevosyan L., Moesta A.K., NormanP.J., Older Aguilar A.M., Guethlein L.A.: Primate-specific regulation ofnatural killer cells. J. Med. Primatol., 2010; 39: 194-212
  Google Scholar
• 82. Pascal V., Yamada E., Martin M.P., Alter G., Altfeld M., MetcalfJ.A., Baseler M.W., Adelsberger J.W., Carrington M., Anderson S.K.,McVicar D.W.: Detection of KIR3DS1 on the cell surface of peripheralblood NK cells facilitates identification of a novel null allele and assessmentof KIR3DS1 expression during HIV-1 infection. J. Immunol.,2007; 179: 1625-1633
  Google Scholar
• 83. Paximadis M., Minevich G., Winchester R., Schramm D.B., GrayG.E., Sherman G.G., Coovadia A.H., Kuhn L., Tiemessen C.T.: KIR-HLAand maternal-infant HIV-1 transmission in Sub-Saharan Africa. PLoSOne, 2011; 6: e16541
  Google Scholar
• 84. Pelak K., Need A.C., Fellay J., Shianna K.V., Feng S., Urban T.J.,Ge D., De Luca A., Martinez-Picado J., Wolinsky S.M., Martinson J.J.,Jamieson B.D., Bream J.H., Martin M.P., Borrow P. i wsp.: Copy numbervariation of KIR genes influences HIV-1 control. PLoS Biol., 2011;9: e1001208
  Google Scholar
• 85. Petitdemange C., Becquart P., Wauquier N., Béziat V., Debré P.,Leroy E.M., Vieillard V.: Unconventional repertoire profile is imprintedduring acute Chikungunya infection for natural killer cellspolarization toward cytotoxicity. PLoS Pathog., 2011; 7: e1002268
  Google Scholar
• 86. Qi Y., Martin M.P., Gao X., Jacobson L., Goedert J.J., BuchbinderS., Kirk G.D., O’Brien S.J., Trowsdale J., Carrington M.: KIR/HLA pleiotropism:protection against both HIV and opportunistic infections.PLoS Pathog., 2006; 2: e79
  Google Scholar
• 87. Qiang Q., Zhengde X., Chunyan L., Zhizhuo H., Junmei X., JunhongA., Zheng C., Henter J.I., Kunling S.: Killer cell immunoglobulin-likereceptor gene polymorphisms predispose susceptibility toEpstein-Barr virus associated hemophagocytic lymphohistiocytosisin Chinese children. Microbiol. Immunol., 2012; 56: 378-384
  Google Scholar
• 88. Rajagopalan S., Long E.O.: KIR2DL4 (CD158d): an activation receptorfor HLA-G. Front. Immunol., 2012; 3: 258
  Google Scholar
• 89. Ravet S., Scott-Algara D., Bonnet E., Tran H.K., Tran T., NguyenN., Truong L.X., Theodorou I., Barré-Sinoussi F., Pancino G., Paul P.:Distinctive NK-cell receptor repertoires sustain high-level constitutiveNK-cell activation in HIV-exposed uninfected individuals.Blood, 2007; 109: 4296-4305
  Google Scholar
• 90. Rivero-Juarez A., Gonzalez R., Camacho A., Manzanares-MartinB., Caruz A., Martinez-Peinado A., Torre-Cisneros J., Pineda J.A.,Peña J., Rivero A.: Natural killer KIR3DS1 is closely associated withHCV viral clearance and sustained virological response in HIV/HCVpatients. PLoS One, 2013; 8: e61992
  Google Scholar
• 91. Romero V., Azocar J., Zúñiga J., Clavijo O.P., Terreros D., Gu X.,Husain Z., Chung R.T., Amos C., Yunis E.J.: Interaction of NK inhibitoryreceptor genes with HLA-C and MHC class II alleles in hepatitisC virus infection outcome. Mol. Immunol., 2008; 45: 2429-2436
  Google Scholar
• 92. Salim P.H., Jobim M., Jobim L.F., Xavier R.M.: Autoimmune rheumaticdiseases and their association with killer immunoglobulin-likereceptor genes. Rev. Bras. Reumatol., 2011; 51: 351-356, 362-364
  Google Scholar
• 93. Scott-Algara D., Truong L.X., Versmisse P., David A., Luong T.T.,Nguyen N.V., Theodorou I., Barré-Sinoussi F., Pancino G.: Cuttingedge: increased NK cell activity in HIV-1-exposed but uninfectedVietnamese intravascular drug users. J. Immunol., 2003; 171: 5663-5667
  Google Scholar
• 94. Single R.M., Martin M.P., Gao X., Meyer D., Yeager M., Kidd J.R.,Kidd K.K., Carrington M.: Global diversity and evidence for coevolutionof KIR and HLA. Nat. Genet., 2007; 39: 1114-1119
  Google Scholar
• 95. Sips M., Sciaranghella G., Diefenbach T., Dugast A.S., Berger C.T.,Liu Q., Kwon D., Ghebremichael M., Estes J.D., Carrington M., MartinJ.N., Deeks S.G., Hunt P.W., Alter G.: Altered distribution of mucosalNK cells during HIV infection. Mucosal Immunol., 2012; 5: 30-40
  Google Scholar
• 96. Song R., Lisovsky I., Lebouché B., Routy J.P., Bruneau J., BernardN.F.: HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cellmediatedinhibition of HIV replication in autologous CD4 targets.PLoS Pathog., 2014; 10: e1003867
  Google Scholar
• 97. Soria A., Guerini F.R., Bandera A., Bolognesi E., Uglietti A., FuscoC., Zucchi P., Maserati R., Rizzardini G., Clerici M., Gori A.: KIR-HLAgenotypes in HIV-infected patients lacking immunological recoverydespite effective antiretroviral therapy. PLoS One, 2011; 6: e27349
  Google Scholar
• 98. Stephens H.A.: Immunogenetic surveillance of HIV/AIDS. Infect.Genet. Evol. J., 2012; 12: 1481-1491
  Google Scholar
• 99. Takeshita L.Y., Gonzalez-Galarza F.F., dos Santos E.J., Maia M.H.,Rahman M.M., Zain S.M., Middleton D., Jones A.R.: A database forcurating the associations between killer cell immunoglobulin-likereceptors and diseases in worldwide populations. Database J. Biol.Databases Curation, 2013; bat021
  Google Scholar
• 100. Tallon B.J., Bruneau J., Tsoukas C.M., Routy J.P., Kiani Z., TanX., Bernard N.F.: Time to seroconversion in HIV-exposed subjectscarrying protective versus non protective KIR3DS1/L1 and HLA-Bgenotypes. PLoS One, 2014; 9: e110480
  Google Scholar
• 101. Tiemessen C.T., Paximadis M., Minevich G., Winchester R.,Shalekoff S., Gray G.E., Sherman G.G., Coovadia A.H., Kuhn L.: Naturalkiller cell responses to HIV-1 peptides are associated with moreactivating KIR genes and HLA-C genes of the C1 allotype. J. Acquir.Immune Defic. Syndr., 2011; 57: 181-189
  Google Scholar
• 102. Tomescu C., Duh F.M., Hoh R., Viviani A., Harvill K., MartinM.P., Carrington M., Deeks S.G., Montaner L.J.: Impact of protectivekiller inhibitory receptor/human leukocyte antigen genotypes onnatural killer cell and T-cell function in HIV-1-infected controllers.AIDS, 2012; 26: 1869-1878
  Google Scholar
• 103. Tomescu C., Duh F.M., Lanier M.A., Kapalko A., Mounzer K.C.,Martin M.P., Carrington M., Metzger D.S., Montaner L.J.: Increasedplasmacytoid dendritic cell maturation and natural killer cell activationin HIV-1 exposed, uninfected intravenous drug users. AIDS,2010; 24: 2151-2160
  Google Scholar
• 104. VandenBussche C.J., Mulrooney T.J., Frazier W.R., DakshanamurthyS., Hurley C.K.: Dramatically reduced surface expressionof NK cell receptor KIR2DS3 is attributed to multiple residuesthroughout the molecule. Genes Immun., 2009; 10: 162-173
  Google Scholar
• 105. Vilches C., Parham P.: KIR: diverse, rapidly evolving receptorsof innate and adaptive immunity. Annu. Rev. Immunol., 2002;20: 217-251
  Google Scholar
• 106. Wauquier N., Padilla C., Becquart P., Leroy E., Vieillard V.: Associationof KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virusinfection. Immunogenetics, 2010; 62: 767-771
  Google Scholar
• 107. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F.,Parham P.: Roles for HLA and KIR polymorphisms in natural killercell repertoire selection and modulation of effector function. J. Exp.Med., 2006; 203: 633-645
  Google Scholar
• 108. Zipeto D., Beretta A.: HLA-C and HIV-1: friends or foes? Retrovirology,2012; 9: 39
  Google Scholar
• 109. Zwolińska K.: Czynniki genetyczne związane z podatnością nazakażenie HIV oraz z progresją zakażenia. Postępy Hig. Med. Dośw.,2009; 63; 73-91
  Google Scholar
• 110. Zwolińska K., Błachowicz O., Tomczyk T., Knysz B., GąsiorowskiJ., Zalewska M., Orzechowska B.U., Sochocka M., Piasecki E.: Theeffects of killer cell immunoglobulin-like receptor (KIR) genes onsusceptibility to HIV-1 infection in the Polish population. Immunogenetics,2016; 68: 327-337
  Google Scholar
• 111. Zwolińska K., Fleischer-Stępniewska K., Knysz B., BłachowiczO., Piasecki E.: Genetic diagnosis of seronegative (HIV−) partner offemale patient with AIDS in the context of HIV transmission. HIVAIDS Rev., 2016; 15: 97-100
  Google Scholar
• 112. Zwolińska K., Knysz B., Rybka K., Pazgan-Simon M., GąsiorowskiJ., Sobczyński M., Gładysz A., Piasecki E.: Protective effect of CCR5-Δ32against HIV infection by the heterosexual mode of transmission ina Polish population. AIDS Res. Hum. Retroviruses, 2013; 29: 54-60
  Google Scholar

Full text